{
  "ticker": "NMR",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02962058",
  "id": "02962058",
  "pages": 4,
  "price_sensitive": false,
  "date": "20250625",
  "time": "1727",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250625/pdf/06l3c06kgxg7ll.pdf",
  "summary": "- **Director's Share Disposal**:  \n  - Blake Cannavo (MD & CEO) indirectly sold **20,000,000 shares** via BOC Holdings Pty Ltd.  \n  - **Consideration**: $3.2 million (off-market sale).  \n  - **Purpose**: Repayment of company debt secured by personal guarantee.  \n\n- **Post-Transaction Holdings**:  \n  - Remaining indirect holdings:  \n    - 142,263,384 shares  \n    - 120,000,000 unlisted options (various strike prices).  \n\n- **No material liquidity/valuation impact**: Disposal was debt-related, not capital markets activity.  \n\nNo other material information identified.",
  "usage": {
    "prompt_tokens": 1740,
    "completion_tokens": 142,
    "total_tokens": 1882,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-25T07:47:01.748754"
}